A few studies indicate that PD-L1 and PD-L2 is overexpressed in higher-risk MDS [22, 23] and that PD-L1 may also be induced by 5-aza treatment [29]. This evidence concerns the gene PDCD1LG2 and myelodysplastic syndrome.